Knowledge, attitude, and practice of COVID-19 screening and vaccine uptake among women attending Maimusari Primary Healthcare in Jere Local Government, North East, Nigeria-Reference-Cited by-同舟云学术

Knowledge, attitude, and practice of COVID-19 screening and vaccine uptake among women attending Maimusari Primary Healthcare in Jere Local Government, North East, Nigeria

Published:2024-02-26 Issue:1 Volume:60 Page:26-37
ISSN:2090-5068
Container-title:Alexandria Journal of Medicine
language:en
Short-container-title:Alexandria Journal of Medicine

Author:

Bello Umar¹,Ja’afar Ibrahim Khalil¹,Ogbolosingha Atieme J.²³,Isa Aliyu⁴,Muhammad Jamilat H.⁵,Abubakar Aisha H.⁶

Affiliation:

1. Department of Community Medicine, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria

2. Department of Life Sciences, Imperial College London, London, UK

3. Department of Biochemistry, Federal University Otuoke, Yenagoa, Nigeria

4. Department of Science Laboratory Technology, Ramat Polytechnic Maiduguri, Maiduguri, Nigeria

5. Department of Family Medicine, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria

6. Department of Pediatrics, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/20905068.2024.2317030

Reference46 articles.

1. World Health Organization (WHO). COVID-19 vaccine tracker and landscape. 2020. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

2. World Health Organization. Whocoronavirus disease (COVID-19) dashboard. 2022a. [cited 2022 April 15]. Available from: https://covid19.who.int/

3. Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy

4. SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring

5. The emergence of COVID-19 and its pandemic potential as a global health security threat and its effect on future life strategy;Al-Sharify ZT;System Rev Pharm,2021